Test your knowledge of musculoskeletal conditions Our self-assessment quiz on musculoskeletal conditions covers the more common disorders that pharmacy staff may encounter, from arthritis and gout to carpal tunnel syndrome.…
NICE recommends first licensed treatment for vitiligo Guidance says that ruxolitinib cream can be used as treatment for vitiligo if other first-line treatments — such as including topical corticosteroids and light therapy — do not work.…
Health news round-up: NICE approvals, surveillance data and GLP-1 warnings A weekly summary of important developments in pharmacy and health news that you may have missed.…
Abatacept could delay rheumatoid arthritis for high-risk patients Researchers found that abatacept was more effective in delaying the progression of rheumatoid arthritis in patients with high levels of anti-citrullinated protein antibody.…
Health news round-up: new NICE guidance, ‘online hospital’ and the environmental burden of medicines A weekly summary of important developments in health news that you may have missed.…
Patient safety alert issued after penicillin allergies incorrectly recorded Penicillin allergies have been recorded as penicillamine allergies in electronic prescribing systems, a “look-alike sound-alike error” that could lead to a potentially fatal anaphylactic reaction.…
Health news round-up: newborns, hormones and a colour-changing label to help spot heat damage Senior clinical reporter Joanna Robertson summarises some important developments in health news you may have missed.…
Rheumatoid arthritis: management An overview of the medicines used for symptom control and disease modification, with consideration given to non-pharmacological approaches that support management of rheumatoid arthritis.…
Coroner issues warning after fatal penicillin treatment The coroner’s report said hospital admission records showed no known drug allergies, despite the patient’s GP record stating an allergy to penicillin.…
MHRA approves first needle-free emergency treatment for anaphylaxis EURneffy, a single-dose nasal spray, is approved for the emergency treatment of anaphylaxis in patients weighing 30kg or more.…
